Kevin Lalande

NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.

Spinal Restoration, Inc. engages in the research and development of early intervention, minimally invasive therapies for the treatment of chronic low back pain. Its solution, the Biostat System, is a propriety resorbable biologic compound and delivery system for the treatment of chronic disc pain. The company was founded in 2004 and is headquartered in Austin, TX.

LDR Spine USA, Inc. offers sterile spinal implant systems. Its product line which includes pre-sterilized fusion devices help in ensuring simple and reliable management of spinal implants. The company was founded in December 1999 and is headquartered in Austin, TX.

Protein Discovery, Inc. is a privately held life sciences company that develops, markets and sells innovative sample preparation products for the measurement of proteins. Their products help academic, biotechnology and pharmaceutical scientists advance their protein research and biotherapeutic development by enabling more sensitive, more accurate, and faster analyses. Protein Discovery is focused on developing and commercializing innovative sample preparation technologies that enable more sensitive, more accurate, and faster protein and peptide analysis using mass spectrometry. PPS Silent Surfactant is a patented detergent that replaces conventional protein extraction and solubilization detergents that either interfere with mass spectrometry or cause other problems in use at the lab bench. The Gelfree 8100 Fractionation System is a patent-pending system that provides molecular weight-based fractionation of intact proteins with liquid phase recovery. And the Passport 1200 Sample Prep System provides enrichment of low molecular weight proteins and peptides for high-throughput quantification applications. Protein Discovery’s innovative sample preparation solutions unlock the power of mass spectrometry for protein and peptide analysis. The company was founded by Charles E. Witkowski II in 2001 and is headquartered in Knoxville, Tennessee.

LDR Holding Corp. is a medical device company, which engages on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. Its products include VerteBRIDGE fusion and Mobi non-fusion platforms. The company was founded by Christophe Lavigne, Herve Dinville and Patrick Richard in 2000 and is headquartered in Warsaw, IN.

BAROnova, Inc. operates as a clinical-stage medical-device company. It develops nonsurgical, nonpharmacologic devices. The firm's TransPyloric Shuttle device enables the patient' stomach to fill up faster, stay full longer, and potentially delay gastric emptying. The company was founded by Hugh Narciso in 2006 and is headquartered in Goleta, CA.

Hospitalists Now, Inc. offers customized hospitalist services. It offers clinical workflow automation, benchmark and dashboard reporting, hospitalist staffing and scheduling, physician communication, ongoing management, and consulting services. The company was founded by Michael Gonzales and Francisco Loya in 2002 and is headquartered in Austin, TX.

Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA.